The predicted effect of targeting IL-10 to improve M2-like macrophage polarization and potentially ischemic tissue perfusion has been recently confirmed in a mouse model of PAD (Gotze et al., 2020). This evidence concerns the gene IL10 and peripheral arterial disease.